Literature DB >> 12800246

Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis.

Wei-Guo Dong1, Qiao Mei, Jie-Ping Yu, Jian-Ming Xu, Li Xiang, Yu Xu.   

Abstract

AIM: To investigate the effects of melatonin (MT) on the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in rat models of colitis.
METHODS: Healthy adult Sprague-Dawlay (SD) rats of both sexes, weighing 280+/-30 g, were employed in the present study. The rat models of colitis were induced by either acetic acid or 2,4,6-trinitrobenzene sulfonic acid (TNBS) enemas. The experimental animals were randomly divided into melatonin treatment and model control group that were intracolicly treated daily with melatonin at doses of 2.5, 5.0, 10.0 mg/kg(-1) and equal amount of saline respectively from 24 h following induction of colitis in rats inflicted with acetic acid enema and the seventh day in rats with TNBS to the end of study. A normal control group of rats treated with neither acetic acid nor TNBS but saline enema was also included in the study. On the 28(th) day of the experiment, the rat colon mucosal damage index (CDMI) was calculated, and the colonic prostaglandin E(2) (PGE(2)), nitric oxide (NO), as well as the iNOS and COX-2 expression were also determined biochemically or immunohistochemically.
RESULTS: CDMI increased to 2.87+/-0.64 and 3.12+/-1.12 respectively in rats treated with acetic acid and TNBS enema, which was in accordance with the significantly elevated colonic NO and PGE(2) contents, as well as the up-regulated colonic iNOS and COX-2 expression in both of the two rat models of colitis. With treatment by melatonin at the doses of 5.0 and 10.0 mg/kg(-1), CDMI in both models of rat colitis was significantly decreased (P<0.05-0.01), which accorded synchronously and unanimously with the reduced colonic NO and PGE(2) content, as well as the down-regulated expression of colonic iNOS and COX-2.
CONCLUSION: Melatonin has a protective effect on colonic injury induced by both acetic acid and TNBS enemas, which is probably via a mechanism of local inhibition of iNOS and COX-2 expression in colonic mucosa.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12800246      PMCID: PMC4611806          DOI: 10.3748/wjg.v9.i6.1307

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Roles of nocturnal melatonin and the pineal gland in modulation of water-immersion restraint stress-induced gastric mucosal lesions in rats.

Authors:  M Otsuka; K Kato; I Murai; S Asai; A Iwasaki; Y Arakawa
Journal:  J Pineal Res       Date:  2001-03       Impact factor: 13.007

Review 2.  Localization, physiological significance and possible clinical implication of gastrointestinal melatonin.

Authors:  G A Bubenik
Journal:  Biol Signals Recept       Date:  2001 Nov-Dec

Review 3.  The immunotherapeutic potential of melatonin.

Authors:  G J Maestroni
Journal:  Expert Opin Investig Drugs       Date:  2001-03       Impact factor: 6.206

4.  Presence of melatonin in the human hepatobiliary-gastrointestinal tract.

Authors:  M Messner; G Huether; T Lorf; G Ramadori; H Schwörer
Journal:  Life Sci       Date:  2001-06-22       Impact factor: 5.037

5.  Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.

Authors:  C Schmidt; B Baumeister; J Kipnowski; B Schiermeyer-Dunkhase; H Vetter
Journal:  Hepatogastroenterology       Date:  1996 Nov-Dec

6.  Melatonin protects against stress-induced gastric lesions by scavenging the hydroxyl radical.

Authors:  D Bandyopadhyay; K Biswas; U Bandyopadhyay; R J Reiter; R K Banerjee
Journal:  J Pineal Res       Date:  2000-10       Impact factor: 13.007

7.  Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis.

Authors:  A D Millar; D S Rampton; C L Chander; A W Claxson; S Blades; A Coumbe; J Panetta; C J Morris; D R Blake
Journal:  Gut       Date:  1996-09       Impact factor: 23.059

8.  Protective effect of famotidine, omeprazole, and melatonin against acetylsalicylic acid-induced gastric damage in rats.

Authors:  G Sener-Muratoğlu; K Paskaloğlu; S Arbak; C Hürdağ; G Ayanoğlu-Dülger
Journal:  Dig Dis Sci       Date:  2001-02       Impact factor: 3.199

9.  Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.

Authors:  Y Raab; C Sundberg; R Hällgren; L Knutson; B Gerdin
Journal:  Am J Gastroenterol       Date:  1995-04       Impact factor: 10.864

Review 10.  Roles of COX-1 and COX-2 in gastrointestinal pathophysiology.

Authors:  C Sakamoto
Journal:  J Gastroenterol       Date:  1998-10       Impact factor: 7.527

View more
  28 in total

1.  Tempol protects the gallbladder against ischemia/reperfusion.

Authors:  Pedro J Gomez-Pinilla; Pedro J Camello; Jesus A F Tresguerres; María José Pozo
Journal:  J Physiol Biochem       Date:  2010-06-23       Impact factor: 4.158

2.  Sleep disorders and inflammatory disease activity: chicken or the egg?

Authors:  Parth J Parekh; Edward C Oldfield Iv; Vaishnavi Challapallisri; J Catsby Ware; David A Johnson
Journal:  Am J Gastroenterol       Date:  2014-08-26       Impact factor: 10.864

3.  The effect of sodium valproate on acetic acid-induced colitis in rats.

Authors:  Ali Najafi; Ehsan Motaghi; Mohammad Javad Hosseini; Masoumeh Ghasemi-Pirbaluti
Journal:  Inflammopharmacology       Date:  2016-12-31       Impact factor: 4.473

4.  Evaluation of enterochromaffin cells and melatonin secretion exponents in ulcerative colitis.

Authors:  Cezary Chojnacki; Maria Wiśniewska-Jarosińska; Grażyna Kulig; Ireneusz Majsterek; Russel J Reiter; Jan Chojnacki
Journal:  World J Gastroenterol       Date:  2013-06-21       Impact factor: 5.742

5.  Altered tryptophan metabolism in human meningioma.

Authors:  Noble Kumar Talari; Manas Panigrahi; Sailaja Madigubba; Sundaram Challa; Prakash Babu Phanithi
Journal:  J Neurooncol       Date:  2016-07-29       Impact factor: 4.130

6.  Change of nitric oxide in experimental colitis and its inhibition by melatonin in vivo and in vitro.

Authors:  Q Mei; J-M Xu; L Xiang; Y-M Hu; X-P Hu; Z-W Xu
Journal:  Postgrad Med J       Date:  2005-10       Impact factor: 2.401

7.  Melatonin attenuates dextran sodium sulfate induced colitis with sleep deprivation: possible mechanism by microarray analysis.

Authors:  Sook Hee Chung; Young Sook Park; Ok Soon Kim; Ja Hyun Kim; Haing Woon Baik; Young Ok Hong; Sang Su Kim; Jae-Ho Shin; Jin-Hyun Jun; Yunju Jo; Sang Bong Ahn; Young Kwan Jo; Byoung Kwan Son; Seong Hwan Kim
Journal:  Dig Dis Sci       Date:  2014-01-16       Impact factor: 3.199

Review 8.  Molecular mechanisms of melatonin's inhibitory actions on breast cancers.

Authors:  Sara Proietti; Alessandra Cucina; Russel J Reiter; Mariano Bizzarri
Journal:  Cell Mol Life Sci       Date:  2012-09-25       Impact factor: 9.261

9.  Relationship between inducible nitric oxide synthase expression and angiogenesis in primary gallbladder carcinoma tissue.

Authors:  Xin-Jie Niu; Zuo-Ren Wang; Sheng-Li Wu; Zhi-Min Geng; Yun-Feng Zhang; Xing-Lei Qing
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

Review 10.  Melatonin: an established antioxidant worthy of use in clinical trials.

Authors:  Ahmet Korkmaz; Russel J Reiter; Turgut Topal; Lucien C Manchester; Sukru Oter; Dun-Xian Tan
Journal:  Mol Med       Date:  2008-11-04       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.